Dietary Omega-7 on Metabolism and Satiety in Adults

Eligibility Details: - INCLUSION CRITERIA: - Male and female participants 18 years of age or above. - Subject must be healthy, with no known history of cardiovascular disease. - Post-menopausal or women of childbearing potential must be non-lactating and using an effective form of birth control during the course of the study. - Subject understands protocol and provides written, informed consent in addition to a willingness to comply with specified follow-up evaluations. - Subjects with a BMI greater than or equal to 25 kg/m2 or a triglycerides level greater than or equal to 100 mg/dL (only one of these parameter need to be met) EXCLUSION CRITERIA: - Pregnancy, planned pregnancy (within the study period) or women currently breastfeeding. - Subjects with allergy or known hypersensitivity to fish, omega-3-acid ethyl esters, omega-7 ethyl esters, other related drugs, or any component of study drugs - Subjects with weight changes greater than 20% over the past 3 months. - Subjects planning a significant change in diet or exercise levels. - Subjects already consuming more than 2 g per day of MUFA, PUFA or other forms of fatty acid supplement if determined by the inverstigator as having a potential to interfere in the data quality or patient safety. - Subjects with chronic diarrhea, gastric bypass or lap-band procedures, ostomies, bowel motility problems, or other known conditions that could affect intestinal fat absorption. - Subjects with any acute and life-threatening condition, such but not limited to as prior sudden cardiac arrest, acute myocardial infarction (last three months), stroke, embolism as per investigator accessment. - Subjects taking supplements or medications that affect lipoproteins for at least the past 8 weeks, such as fish oil supplements, bile-acid sequestrants, plant sterol supplements, fibrates, statins, Niacin or PCSK9 inhibitors. - Subjects being treated with tamoxifen, estrogens, or progestins that have not been stable for >4 weeks. - Subjects initiating new medications or patients on multiple medications may also be excluded according to investigator discretion - Anticipated surgery during the study period - Liver enzymes (AST or ALT) levels above 3x upper limit of normal - Blood donation in the last 2 weeks or planned blood donation during the study - Subjects requiring regular transfusions for any reason - Subjects may also be excluded for any reason that may compromise their safety or the accuracy of research data. - Abnormal baseline laboratory values that are considered not clinically significant by the PI will not exclude the subject.